CD274 and neoplasm: Programmed cell death-1 (PD-1) receptors are up-regulated on activated T cells and interact with programmed cell death ligand 1 (PD-L1) on the surface of tumor cells and immune cells to produce immunosuppression to weaken the body's anti-tumor effect [29].